Phase I dose‐escalation trial investigating volasertib as monotherapy or in combination with cytarabine in patients with relapsed/refractory acute myeloid leukaemia. (8th June 2018) - Ottmann, Oliver G.; Müller‐Tidow, Carsten; Krämer, Alwin; Schlenk, Richard F.; Lübbert, Michael; Bug, Gesine; Krug, Utz; Bochtler, Tilmann; Voss, Florian; Taube, Tillmann; Liu, Dan; Garin‐Chesa, Pilar; et al.